Valuation: Abbott Laboratories

Market Cap 18TCr 16TCr 15TCr 13TCr 25TCr 16,85400Cr 25TCr 1,77100Cr 69TCr 8,76500Cr 67TCr 65TCr 28,12700Cr P/E 2026 *
30.3x
P/E 2027 * 23.5x
Enterprise Value 20TCr 18TCr 17TCr 15TCr 29TCr 19,12600Cr 29TCr 2,01000Cr 79TCr 9,94700Cr 76TCr 74TCr 31,91900Cr EV / Sales 2026 *
4.01x
EV / Sales 2027 * 3.64x
Free-Float
86.16%
Yield 2026 *
2.5%
Yield 2027 * 2.67%
1 day-0.21%
1 week+4.53%
Current month+3.82%
1 month+0.65%
3 months+11.40%
6 months+1.91%
Current year-18.10%
1 week 97.2
Extreme 97.2
103.44
1 month 95.06
Extreme 95.06
104.54
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
132.02
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
30/09/26 Free

Director

333 0.0000%
30/09/26 Free

Director

318 0.0000%
30/09/26 Free

Director

381 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%+4.53%-21.90%+12.92% 18TCr
+1.17%+6.80%-2.69%+29.25% 12TCr
-0.02%+1.56%-22.57%+9.57% 11TCr
+2.53%+2.32%-44.88%-9.40% 7.53TCr
+1.55%+4.34%+4.14%+74.68% 6.3TCr
+0.34%+1.05%+19.75%+67.00% 5.35TCr
-0.80%+3.92%+0.38%-27.57% 5.1TCr
-0.69%+0.95%-17.84%+22.09% 4.1TCr
-1.00%+2.00%+30.46%+11.64% 3.21TCr
-0.17%+0.42% - - 3.13TCr
Average +0.17%+2.32%-6.13%+21.13% 7.52TCr
Weighted average by Cap. +0.23%+3.04%-11.72%+19.79%

Financials

2026 *2027 *
Net sales 5.02TCr 4.48TCr 4.18TCr 3.79TCr 7.13TCr 4,76500Cr 7.19TCr 50TCr 20TCr 2,47800Cr 19TCr 18TCr 7,95200Cr 5.45TCr 4.87TCr 4.54TCr 4.12TCr 7.75TCr 5,17600Cr 7.81TCr 54TCr 21TCr 2,69200Cr 20TCr 20TCr 8,63800Cr
Net income 616.29Cr 550.53Cr 513.14Cr 465.23Cr 875.53Cr 58TCr 882.4Cr 6.15TCr 2.41TCr 30TCr 2.31TCr 2.26TCr 98TCr 784.29Cr 700.61Cr 653.03Cr 592.05Cr 1.11TCr 74TCr 1.12TCr 7.82TCr 3.06TCr 39TCr 2.95TCr 2.88TCr 1,24200Cr
Net Debt 2.39TCr 2.14TCr 1.99TCr 1.81TCr 3.4TCr 2,27200Cr 3.43TCr 24TCr 9.35TCr 1,18200Cr 8.99TCr 8.79TCr 3,79200Cr 2.1TCr 1.87TCr 1.74TCr 1.58TCr 2.98TCr 1,98900Cr 3TCr 21TCr 8.18TCr 1,03500Cr 7.87TCr 7.7TCr 3,32000Cr
Projected Income Statement - Annual - Abbott Laboratories
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change Volume
13/26/13 $102.61 +0.78% 98,64,564
12/26/12 $101.82 +2.23% 71,47,039
09/26/09 $99.60 +1.13% 69,62,016
08/26/08 $98.49 -0.24% 1,39,09,636
07/26/07 $98.73 +0.58% 93,92,437
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Abbott Laboratories
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
102.61USD
Average target price
120.72USD
Spread / Average Target
+17.64%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Abbott Laboratories